All together, these data indicated that rpS6 is involved in the invasion and migration capabilities of NSCLC cells, which might explain the clinical metastasis of NSCLC patients with the abnormal activation of rpS6. This evidence concerns the gene RPS6 and non-small cell lung carcinoma.